2 results match your criteria: "University of Rochester Medical and Dental School[Affiliation]"
Current practice patterns in the perioperative management of patients undergoing radical cystectomy: Results from a global survey.
Urol Oncol
May 2022
Adjunct Professor, University of Rochester Medical and Dental School, Rochester, NY.
Objective: To determine current practice patterns and adherence to various components of enhanced recovery after surgery in cystectomy (ERAC) protocol for peri-operative management of radical cystectomy patients through a global survey.
Methods: A survey containing 25 questions and addressing 15 of the 22 items of the ERAC protocol was developed and disseminated through Email to the urologists with recent bladder cancer publications. The mailing list was generated by retrieving Email-ids of corresponding authors of articles using the keyword "cystectomy" in Scopus from January 2018 to October 2020.
Increased Insulin mRNA Binding Protein-3 Expression Correlates with Vascular Enhancement of Renal Cell Carcinoma by Intravenous Contrast-CT and is Associated with Bone Metastasis.
J Bone Oncol
September 2015
Department of Orthopaedics, University of Rochester Medical Center, Rochester, New York, United States of America ; Center for Musculoskeletal Research, University of Rochester Medical and Dental School, Rochester, New York, United States of America.
Purpose: To: 1) assess the correlation between CT vascularity and a candidate molecular marker of RCC metastasis (insulin-like mRNA binding protein-3 (IMP3)); and 2) demonstrate the differential expression of IMP3 in high vs. low vascular tumors.
Experimental Design: Retrospectively obtained contrast CT from 72 patients with primary RCC were used to establish threshold values for Low, Intermediate and High tumor vascularity.